Robert Sidbury, MD, MPH, chief, Division of Dermatology, Seattle Children's Hospital, discussed the psychosocial and behavioral issues faced by patients with atopic dermatitis, particularly those with severe disease.
For patients with a severe course of atopic dermatitis, emerging research has identified significant psychosocial and behavioral comorbidities in these patient populations, said Robert Sidbury, MD, MPH, chief, Division of Dermatology, Seattle Children's Hospital.
Sidbury recently served as co-author of a study published in the Journal of the American Academy of Dermatology, titled, "AAD Guidelines: awareness of comorbidities associated with atopic dermatitis in adults."
Transcript
Psychosocial distress and behavioral problems have been identified in patients with atopic dermatitis. Can you discuss this association and recommendations for intervention?
For sure, it's been the last few years where some really important publications have come out highlighting this. Something that I think those of us who've treated patients with this condition, or at least patients on the more severe end of the spectrum with this condition, for years have known about, just because it's so impactful. And it's tricky because eczema—I'm a pediatric dermatologist so I just see kids.
I've obviously been involved in the guideline committee for the American Academy of Dermatology for adults as well, and that's the nature of the publication that we're talking about right now, but we've known that this is a condition that itches 24/7. Certainly, before biologics and the more recent therapies, we've not had great treatments, we've had good treatments, but not great treatments for it. And so it's always tough for me, because I hear the phrase: just eczema—oh, it's just eczema.
For kids who use a little vaseline it goes away, doesn't really keep them up at night—yeah, it is just eczema. But for the more severe end of the spectrum, it's just a different animal entirely. And for those kids, if you kind of imagine yourself having an itchy rash or a bug bite or something, it can be incredibly distracting, and even painful for the relatively short duration that you deal with it.
These are kids who deal with this or adults who deal with this 24/7. And so you might imagine in such a circumstance, particularly when your provider can't say: okay, well, I'm going to give you medicine, it'll be done in 2 weeks. No, this is a condition that's chronic, we've not had a cure, still don't have a cure, we just have better treatments. And so that context of a constantly itchy condition for which there's no clear end point, think about the psychological stress that would impose upon someone.
So, we've known about that. Now, some papers in the last few years have fleshed that out, and this paper that we've talked about—the comorbidity paper that was just published in the Journal of the American Academy of Dermatology, the JADD, it did show that atopic dermatitis is associated with depression, is associated with anxiety, some less certain associations with other things such as substance abuse, alcohol, cigarettes, but these are important things to be aware of.
At the very least, to discuss how effectively patients are being treated to try and mitigate the impacts on other aspects of their life and even to in cases pointedly question, how are our patients doing? Psychologically, how are they coping? What are the impacts of these diseases psychosocially? Because a lot of times if we don't ask, we won't know. And this literature is suggesting that in many, many patients we very much should ask.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
BRCA-Like Classification May Be a Useful Biomarker for Olaparib Response in Ovarian Cancer
May 1st 2024Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ovarian cancer whose tumors have a BRCA-like genomic profile, but not among those with non-BRCA-like tumors, a study found.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
BRCA-Like Classification May Be a Useful Biomarker for Olaparib Response in Ovarian Cancer
May 1st 2024Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ovarian cancer whose tumors have a BRCA-like genomic profile, but not among those with non-BRCA-like tumors, a study found.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More
2 Commerce Drive
Cranbury, NJ 08512